Discontinuing Bevacizumab in Patients with Glioblastoma: An Ethical Analysis

Glioblastoma (GBM) is a highly lethal malignant brain tumor that expresses proangiogenic factors, including vascular endothelial growth factor (VEGF). Bevacizumab (Avastin®; Genentech, Inc., South San Francisco, CA), a monoclonal antibody against VEGF, is routinely used in the U.S. to treat GBM pati...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Kesselheim, Jennifer C., Norden, Andrew D., Wen, Patrick Y., Joffe, Steven
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2011
Fag:
Medical Ethics
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228073/
https://ncbi.nlm.nih.gov/pubmed/21948651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0047
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker